Location:
Webinar via Zoom
Please click on the link just before the start of the webinar
Cost
Free
Contact for enquiries
gbuckland@kirby.unsw.edu.au
Please join us as we present the findings of the first report on progress towards hepatitis C elimination among Aboriginal and Torres Strait Islander people in Australia.
Unrestricted access to government subsidised direct-acting antiviral therapy for hepatitis C has seen treatment success for large numbers of Aboriginal and Torres Strait Islander people, with some declines in hepatitis C related liver failure and mortality. However, there are gaps in treatment uptake and harm reduction coverage, particularly among young Aboriginal and Torres Strait Islander men.
The panel of speakers from the Kirby Institute, NACCHO, Hepatitis Australia and the Australian Government Department of Health will the discuss the report’s finding and how they can inform Aboriginal community-led strategies for hepatitis C elimination.
Chaired by:
Robert Monaghan, Manager, Aboriginal and Torres Strait Islander Health Program, Kirby Institute, UNSW Sydney
Speakers
- Emily Phillips, Director of Communicable Diseases, National Aboriginal Community Controlled Health Organisation
- Co-presenters: Donna Garcia, Hepatitis WA and Carrie Fowlie, CEO, Hepatitis Australia
- Greg Dore, Program Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney
- Sahar Bajis, Lecturer, Public Health Interventions Research Program and Viral Hepatitis Clinical Research Program
- Stuart Manoj-Margison, Director, BBV, STI and Torres Strait Health Policy Section, Australian Government Department of Health
Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.